Small

Zacks Small Cap Research – MGRM: Monogram’s Potential for Profitable Long-Term Growth Supports Price Target of $6.00. – Go Health Pro

by

By Thomas Kerr, CFA NASDAQ:MGRM READ THE FULL MGRM RESEARCH REPORT Monogram (NASDAQ:MGRM) reported 3rd quarter 2024 financial results on November 14th which were largely in line with expectations. Research and development expenses for the quarter ending September 30, 2024 were $2.2 million compared to $2.7 million in the prior year period. The R&D decrease … Read more

Zacks Small Cap Research – CLPMF: Clip Money Reports Q3 Revenue Growth of 250% – Go Health Pro

by

By Lisa Thompson OTC:CLPMF READ THE FULL CLPMF RESEARCH REPORT Revenue is ramping even faster than we expected, as shown by the Q3 earnings report. Revenue for Q3 2024 was $521,000 compared to $149,000 in Q3 of 2023, representing 250% growth. In the quarter, the number of new deposit users grew by 101%, and revenue … Read more

Zacks Small Cap Research – BSEM: Medicare Issues Shouldn’t Impact BioStem – Go Health Pro

by

By Brad Sorensen, CFA OTC:BSEM READ THE FULL BSEM RESEARCH REPORT We don’t often write about short-term movements in stocks we cover but the move in BioStem Technologies, Inc. (OTC:BSEM) has coincided with what seems to have been perceived as a fundamental change in the company and we want to make sure investors know the … Read more

Zacks Small Cap Research – BENF: F2Q25 Earnings Review: Improving Financial Performance; Pivoting to Growth – Go Health Pro

by

By Michael Kim NASDAQ:BENF READ THE FULL BENF RESEARCH REPORT After the market closed on 11/14/24, Beneficient (NASDAQ:BENF) reported F2Q25 (Sep) earnings results. On a GAAP basis, BENF reported net income of $0.03 per Class A diluted share for F2Q25 – the company’s second consecutive profitable quarter as a public company – versus a loss … Read more

Zacks Small Cap Research – EVAX Racks up Positive Test Results – Go Health Pro

by

By Brad Sorensen, CFA NASDAQ:EVAX READ THE FULL EVAX RESEARCH REPORT Evaxion (NASDAQ:EVAX) is a clinical stage company that is making AI useful in the current environment by using the technology to develop new cancer-fighting vaccines. The company notes that it has demonstrated that it can identify, through the company’s AI models, novel targets within … Read more

x